A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples